SAShailendra Anjankar

Shailendra Anjankar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shailendra Anjankar has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Primary cervical spinal cord intramedullary spindle cell melanoma: A rare case report

    by Pavan Tulshiram Lanjewar, Charandeep Singh Gandhoke, Simran Kaur Syal, Shailendra Anjankar, Binoy Kumar Singh, Ashish Kumar Gupta

    Background: Primary melanoma of the spinal cord is an extremely rare tumor. Only about less than 70 cases have been reported till date. Case Description: Our case is a 40-year-old male patient who presented with complaints of progressive right upper and lower limb weakness for the past 6 months. Radiology revealed an intramedullary lesion at C5-C6 level with proximal and distal syrinx. The patient underwent gross total excision of the tumor. The histopathological findings were suggestive of spindle cell melanoma. Post-operative whole body positron emission tomography – computed tomography imaging, dermatological and ophthalmological evaluation ruled out any similar lesions elsewhere. Conclusion: Rarity of primary cervical intramedullary spindle cell melanoma and gross total excision with good surgical outcome prompted us to report this case.


  • Open Access

    Pathological laughter as an unusual first-presenting symptom of petroclival meningioma

    by Pavan Tulshiram Lanjewar, Mayank Tripathi, Simran Kaur Syal, Binoy Kumar Singh, Shailendra Anjankar, Charandeep Singh Gandhoke

  • Open Access

    Rhinocerebral mucormycosis (RCM): To study the clinical spectrum and outcome of 61 cases of RCM managed at a tertiary care center in India

    by Anil Kumar Sharma, Nitin M. Nagarkar, Charandeep Singh Gandhoke, Siddharth Sharma, Mohit Juneja, Zijano M. Kithan, Aakash Aggarwal, Ripu Daman Arora, Rupa Mehta, Simran Syal, et al.

    Background: Mucormycosis is a life-threatening infection of the paranasal sinuses and nasal cavities that can easily spread to the orbit and the brain. It is caused by fungi of the family Mucoraceae. We present a case series of 61 patients diagnosed and treated for rhinocerebral mucormycosis (RCM) at a single tertiary health care center. Methods: After obtaining ethical clearance, all patient files with a final diagnosis of RCM were thoroughly analyzed in departmental records and a master chart was prepared. The study evaluated the etiology, clinical spectrum, diagnosis, management, complications, and outcome at 3 months of RCM cases. Results: About 93.4% of the RCM cases were diabetic and an equal number had a past history of COVID infection. About 85.2% had received steroids for the treatment of coronavirus disease 2019 infection. The most common presentation of RCM was temporal lobe abscess (25.7%) followed by frontal lobe abscess (16.6%). At 3 months post-diagnosis, mortality in our study was 42.6%. About 26.2 % of the RCM cases had no disease, 23% had a static disease, and 8.2% had progressive disease at the end of 3 months. Conclusion: We report the largest single-center case series of RCM, comprising 61 patients. This case series underscores the importance of the early diagnosis and prompt treatment for a better prognosis for this dreadful disease. The three pillars of treatment for RCM cases include reversal of the immunosuppressive state, administration of antifungal drugs, and extensive surgical debridement. In spite of all this, mortality remains high.